CA Patent

CA2274943A1 — Compositions for the treatment and prevention of inflammatory diseases of the gastrointestinal tract and methods and uses thereof

Assigned to Individual · Expires 1999-12-17 · 26y expired

What this patent protects

Novel compositions for the treatment of inflammatory diseases of the gastrointestinal tract, preferably ulcerative proctitis, ulcerative colitis, Crohn's colitis, radiation proctitis and pouchitis are described. Compositions comprising more than one active agent such as: 5-ASA; a…

USPTO Abstract

Novel compositions for the treatment of inflammatory diseases of the gastrointestinal tract, preferably ulcerative proctitis, ulcerative colitis, Crohn's colitis, radiation proctitis and pouchitis are described. Compositions comprising more than one active agent such as: 5-ASA; a topical steroid such as, budesonide or an R-epimer thereof; and optionally metronidazole, which are more effective than the use of any of these agents alone are also described.

Drugs covered by this patent

Patent Metadata

Patent number
CA2274943A1
Jurisdiction
CA
Classification
—
Expires
1999-12-17
Drug substance claim
No
Drug product claim
No
Assignee
Individual
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.